Clinical trials
Phase 2 trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,844 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 15 |
| 2002 | 20 |
| 2003 | 28 |
| 2004 | 49 |
| 2005 | 79 |
| 2006 | 106 |
| 2007 | 137 |
| 2008 | 124 |
| 2009 | 145 |
| 2010 | 129 |
| 2011 | 169 |
| 2012 | 167 |
| 2013 | 133 |
| 2014 | 148 |
| 2015 | 158 |
| 2016 | 155 |
| 2017 | 200 |
| 2018 | 190 |
| 2019 | 224 |
| 2020 | 232 |
| 2021 | 263 |
| 2022 | 209 |
| 2023 | 204 |
| 2024 | 200 |
| 2025 | 219 |
| 2026 | 114 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,218 |
| Terminated | 649 |
| Active, not recruiting | 374 |
| Recruiting | 352 |
| Unknown status | 157 |
| Withdrawn | 45 |
| Not yet recruiting | 31 |
| Enrolling by invitation | 13 |
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 217 |
| Hoffmann-La Roche | 158 |
| Pfizer | 133 |
| GlaxoSmithKline | 126 |
| AstraZeneca | 114 |
| Sanofi | 98 |
| Bristol-Myers Squibb | 97 |
| Janssen Research & Development, LLC | 83 |
| Eli Lilly and Company | 79 |
| Bayer | 78 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 231 |
| Carcinoma, Non-Small-Cell Lung | 210 |
| Neoplasms | 115 |
| Colorectal Neoplasms | 114 |
| Neoplasm Metastasis | 101 |
| Arthritis, Rheumatoid | 75 |
| Recurrence | 68 |
| Ovarian Neoplasms | 67 |
| Melanoma | 64 |
| Multiple Myeloma | 61 |
Trials
Showing 1 to 25 of 3,844. Each trial links to its page on Pharma Observatory.
3,744 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.